Xcout IntelInotrem
Inotrem is a French clinical-stage biotechnology company developing therapies for dysregulated innate immune responses and inflammation. Its lead candidate, nangibotide (LR12)…
The full profile of Inotrem
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Inotrem →Already a subscriber? Sign in
Xcout Intel tracks Inotrem continuously — this profile deepens as new filings, funding, people and hiring data arrive.